EUVIMEDEUVIMED entdecken
Crossref

Chemometry and Green Chemistry-Based Chromatographic Analysis of Azilsartan Medoxomil, Cilnidipine and Chlorthalidone in Human Plasma Using Analytical Quality by Design Approach

Pintu Prajapati iD, Abhinandan Shahi, Aneri Acharya, Shailesh Shah

Journal of Chromatographic Science · 2024

DOI: 10.1093/chromsci/bmac068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chromatographic Science, 2024. Verfasst von Pintu Prajapati und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Quality Assurance, Maliba Pharmacy College, Maliba Campus, Bardoli-Mahuva Road, Tarsadi, Mahuva, Surat 394 350, Gujarat, India. Hauptthemen laut MEDLINE: Chlorthalidone, Chemometrics, Benzimidazoles, Dihydropyridines. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

According to the green chemistry approach, the usage of carcinogenic and teratogenic organic solvents should be minimized in the development of the analytical method for the safety of the environment and analysts. According to the literature review, no high-performance thin-layer chromatographic (HPTLC) method has been reported yet for concomitant analysis of azilsartan medoxomil (AZM), chlorthalidone (CTD) and cilnidipine (CDP) in human plasma. Hence, a robust and accurate HPTLC method has been developed using safe and non-toxic organic solvents for the concomitant analysis of AZM, CTD and CDP in human plasma, fixed-dose combinations (FDCs) and laboratory mixtures. The HPTLC method was developed by the implementation of the analytical quality by design approach using principles of quality risk management and design of experiments (DoE) for regulatory compliance. The principal component analysis was applied for the risk assessment and analysis of potential method variables in the method development. The principle of DoE was used for the response surface modeling to link identified critical method risk parameters with critical method performance attributes using full factorial design (FFD). The method operable design region and analytical control space were navigated for the optimization of the method as per quality target analytical profile. The developed method was also applied for concomitant analysis of AZM, CTD and CDP in their FDCs and laboratory mixture and results were found in good agreement with the labeled amount of the respective drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChlorthalidoneChemometricsBenzimidazolesDihydropyridinesOxadiazolesHumansSolventsChromatography, High Pressure Liquid

Substanzen

Chlorthalidoneazilsartan medoxomilcilnidipineSolventsBenzimidazolesDihydropyridinesOxadiazoles

Autor:innen und Institutionen

  • Department of Quality Assurance, Maliba Pharmacy College, Maliba Campus, Bardoli-Mahuva Road, Tarsadi, Mahuva, Surat 394 350, Gujarat, India.

ORCID-Profile: Pintu Prajapati

Zitieren

APA

Prajapati, P., Shahi, A., Acharya, A., & Shah, S. (2024). Chemometry and Green Chemistry-Based Chromatographic Analysis of Azilsartan Medoxomil, Cilnidipine and Chlorthalidone in Human Plasma Using Analytical Quality by Design Approach. Journal of Chromatographic Science. https://doi.org/10.1093/chromsci/bmac068

Vancouver

Prajapati P, Shahi A, Acharya A, Shah S. Chemometry and Green Chemistry-Based Chromatographic Analysis of Azilsartan Medoxomil, Cilnidipine and Chlorthalidone in Human Plasma Using Analytical Quality by Design Approach. Journal of Chromatographic Science. 2024. doi:10.1093/chromsci/bmac068

BibTeX
@article{Prajapati2024,
  author = {Prajapati, Pintu and Shahi, Abhinandan and Acharya, Aneri and Shah, Shailesh},
  title = {Chemometry and Green Chemistry-Based Chromatographic Analysis of Azilsartan Medoxomil, Cilnidipine and Chlorthalidone in Human Plasma Using Analytical Quality by Design Approach},
  journal = {Journal of Chromatographic Science},
  year = {2024},
  doi = {10.1093/chromsci/bmac068}
}
Kostenlos starten →